Scroll Back to Top


Complementary use of DNA- and RNA-based NGS assays optimizes detection of clinically relevant translocations for comprehensive genomic profiling

Christopher Coldren(1), Jennifer B Jackson(2), Jacob Kames(2), David Riley(2), Scott Wheeler(1), Pranil Chandra(1), and Michelle Shiller(1)
(1) PathGroup, Nashville, TN 37217, USA; (2) Personal Genome Diagnostics (Labcorp), Baltimore, MD 21224, USA

Event: AACR 2023